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ABSTRACT
Background    Breast ultrasound findings regarding tu-
mor margins are crucial in judging whether a tumor is 
malignant or benign. However, the relationships between 
the margins and clinicopathological characteristics re-
main largely unknown. In this study, we examined the 
clinicopathological characteristics of patients with inva-
sive ductal carcinoma whose ultrasound images showed 
either well-defined and rough or indistinct margins. 
Methods    Of all consecutive patients diagnosed with 
invasive ductal carcinoma at the Division of Breast and 
Endocrine Surgery of Tottori University Hospital from 
January 2012 to December 2014, 122 patients whose 
ultrasound images showed either “well-defined and 
rough” or “indistinct” tumor margins were included in 
this study. Mammography and ultrasound images taken 
at the initial examination were reviewed. Patients were 
divided into two groups based on ultrasound findings of 
the tumor margins: the “well-defined and rough group” 
and the “indistinct group.” The relationships among 
ultrasound findings, mammography findings and clin-
icopathological findings were investigated in the two 
groups.  
Results    The well-defined and rough group was more 
likely to contain solid-tubular carcinoma, while the 
indistinct group was more likely to contain scirrhous 
carcinoma. The MIB-1 index was higher in the well-de-
fined and rough group than in the indistinct group. Ad-
ditionally, the proportion of patients with nuclear grade 
3, estrogen receptor-negative/progesterone receptor-neg-
ative, and triple-negative breast cancer was greater in 
the well-defined and rough group than in the indistinct 
group. 
Conclusion    Invasive ductal carcinomas with well-de-
fined and rough margins on ultrasound were likely to 
be malignant and proliferative than those with indistinct 
margins. 
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Breast ultrasound findings, such as the shape, margins, 
posterior features, and depth/width ratio of a tumor, 
play an important role in judging whether the tumor is 
malignant or benign.1, 2 Hong et al.1 reported that 90% 
of tumors with circumscribed margins on ultrasound 
were benign, while 86% of those with spiculated mar-
gins were malignant. Rahbar et al.2 reported that 91% of 
tumors with circumscribed margins were benign, 67% 
of those with spiculated or microlobulated margins were 
malignant, and 50% of those with ill-defined margins 
were malignant.
 The Guidelines for Breast Ultrasound Diagnosis by 
the Japan Association of Breast and Thyroid Sonology3 
state that the margins of tumor lesions can be grouped 
into circumscribed, well-defined and rough, or indis-
tinct. These guidelines also state that tumors with cir-
cumscribed margins are more likely to be benign, while 
tumors with the other two types of margins are likely to 
be malignant.3 In breast cancer, the relationship between 
clinicopathological characteristics and the type of tumor 
margins judged on ultrasound has rarely been investigat-
ed. 
 We examined the clinicopathological characteristics 
of invasive ductal carcinoma showing either well-defined 
and rough or indistinct margins on ultrasound.
SUBJECTS AND METHODS
Patients
Of all consecutive 204 patients diagnosed with invasive 
ductal carcinoma at the Division of Breast and Endo-
crine Surgery of Tottori University Hospital from Janu-
ary 2012 to December 2014, six patients with a history 
of breast cancer, 21 invasive carcinoma of special types, 
32 noninvasive carcinoma, 17 patients with treatment 
of neoadjuvant chemotherapy, three bilateral carcinoma 
were excluded. Of the other 125 patients, three patients 
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whose ultrasound images showed circumscribed of 
the tumor margins were excluded because they are too 
small population to analyze the relationship between the 
ultrasound images of the tumor margins and their clini-
copathological characteristics. Thus, 122 patients whose 
ultrasound images showed either “well-defined and 
rough” or “indistinct” tumor margins were included in 
this study. Mammography and ultrasound images taken 
at the initial examination were reviewed.
 The largest masses were evaluated in patients with 
multicentric breast cancer.
Clinical findings
Age, levels of tumor markers (carcinoembryonic antigen 
and cancer antigen 15-3) and menopause status were in-
vestigated. 
Imaging analysis
The findings of mammography and ultrasound exam-
inations performed at the initial examination were re-
viewed. Patients were divided into the well-defined and 
rough group and the indistinct group based on the ultra-
sound findings of the tumor margins. Well-defined and 
rough margins were defined as relatively clear but rough 
interfaces between tumor and non-tumor regions, while 
indistinct margins were defined as unclear interfaces 
between the above two regions (Figs. 1A and B). There 
were 38 tumors with two types of tumor margins. Such 
cases were classified as a margin of more widely recog-
nition. 
 Ultrasound examinations were performed with ei-
ther a HI VISION Preirus diagnostic ultrasound system 
(Hitachi Aloka Medical, Tokyo, Japan) with a EUP-
L74M linear probe (5.0–13.0 MHz) or a Noblus system 
(Hitachi Aloka Medical) with a EUP-L75 linear probe 
(5.0–18.0 MHz). 
 Ultrasound findings were analyzed based on the 
Guidelines for Breast Ultrasound Diagnosis (3rd edi-
tion),3 and the following parameters were assessed: tu-
mor size, homogeneity (homogeneous or heterogeneous), 
posterior features (accentuation, unchanging, or shad-
owing), echogenic foci (present or absent), interruption 
of the interface between adipose tissue and mammary 
gland (present or absent), and depth/width ratio (< 0.7 or 
≥ 0.7). 
 Mammographic findings were analyzed based on 
the Mammography Guideline (3rd expanded edition),4 
and the following parameters were assessed: microcalci-
fication (present or absent), architectural distortion (pres-
ent or absent), and breast density (< 50% or ≥ 50%). 
 Ultrasound images were reviewed individually by 
a medical breast cancer specialist with > 25 years of 
experience and an ultrasonographer with > 2 years of 
experience. Mammography images were reviewed by 
two medical breast cancer specialists with > 25 years of 
experience in breast examination. All examiners were 
blinded to the patients’ information during the evalua-
tion. If there was disagreement in the evaluation of find-
ings, a final decision was reached by consensus. 
Histological analysis
In all cases, we examined the histological classification, 
expression of hormone receptors [estrogen receptor (ER) 
and progesterone receptor (PgR)], expression of human 
epidermal growth factor receptor type 2 (HER2), lym-
phatic vessel invasion, blood vessel invasion, nuclear 
grade, lymph node metastasis, and MIB-1 index. The 
histological classifications were classified into papillotu-
bular carcinoma, solid-tubular carcinoma, and scirrhous 
carcinoma in accordance with the General Rules for 
Clinical and Pathological Recording of Breast Cancer 
(17th edition),5 and nuclear types were also classified 
into grades 1 to 3. Intrinsic subtypes were classified 
in accordance with the St. Gallen International Expert 
Consensus on the Primary Therapy of Early Breast 
Cancer 2013.6 Luminal A, luminal B, and HER2-posi-
tive breast cancer was termed non-triple-negative breast 
cancer (non-TNBC) and compared with triple-negative 
breast cancer (TNBC). 
A B
Fig. 1. Ultrasound findings of tu-
mor margin. 
A: An ultrasound image showed 
a well-defined and rough margin 
with posterior accentuation. 
B: An ultrasound image showed 
an indistinct margin with posterior 
shadowing.
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Statistical analysis
The relationships among ultrasound findings, mammog-
raphy findings and clinicopathological findings were 
investigated with respect to tumor margins in the two 
groups. Statistical analyses were performed with the 
use of statistical software, SPSS, version 23.0 (IBM, 
Armonk, NY), and P < 0.05 indicated a statistically 
significant difference. Quantitative data were analyzed 
using Fisher’s exact test and Pearson’s chi-square test, 
while continuous data were analyzed using the Mann–
Whitney U test.
 This study was approved by the Ethics Committee 
of the Tottori University Medical School (approval num-
ber 2103). 
RESULTS 
All patients were women with a mean age of 61 years 
(range, 28–88 years). There were no significant differ-
ences in age, tumor marker levels or menopause status 
between the two groups (Table 1). 
 The 122 patients were grouped into the well-defined 
and rough group (n = 49) and the indistinct group (n = 
73). Accentuation of posterior features was observed 
more frequently in the well-defined and rough group, 
while shadowing was observed more frequently in the 
indistinct group (P < 0.001) (Table 2). There were no re-
lationships between ultrasound findings regarding mar-
gins and mammography findings (Table 3). 
 The pathological examination results are shown 
in Table 4. Tumors in the well-defined and rough 
group were more likely to be solid-tubular carcinomas, 
ER-negative, PgR-negative, nuclear grade 3, and TNBC 
(P = 0.003) and to have a higher MIB-1 index. Converse-
ly, tumors in the indistinct group were more likely to be 
scirrhous carcinomas (P < 0.001), ER-positive (P < 0.05), 
PgR-positive (P < 0.01), and nuclear grade 1 (P = 0.001) 
and to have a lower MIB-1 index (P = 0.001).
Table 1. Relationships between tumor margin type 
and clinical findings
Margin
Well defined 
and rough Indistinct P-value
Age, years old 60 (48–70) 62 (53–70) 0.441 
CEA, ng/mL 1.9 (1.1–3.0) 1.6 (1.2–2.7) 0.450 
CA15-3, U/mL 11.9 (8.3–16.0) 11.1 (9.3–17.8) 0.766 
Menopausal status 0.186 
Premenopausal 14 13
Postmenopausal 35 60
All variables are reported as median (interquartile range).
CA15-3, cancer antigen 15-3; CEA, carcinoembryonic antigen.
Table 2. Relationships between tumor margin type 
and ultrasound findings
Margin
Well defined 
and rough Indistinct P-value
Tumor size, mm 17.1 (13.8–23.5) 15.2 (11.0–22.8) 0.911 
Homogeneity 0.072 
 Homogeneous 6 19
 Heterogeneous 43 54
Posterior features < 0.001 
 Accentuation 28 13
 Unchanging 15 32
 Shadowing 6 28
Echogenic foci 0.707 
 Present 21 28
 Absent 28 45
Interrupting of the 
interface between 
adipose tissue and 
gland
0.635 
 Present 39 61
 Absent 10 12
Depth/width ratio 0.357 
 < 0.7 23 28
 ≥ 0.7 26 45
Variables of tumor size are reported as median (interquartile 
range).
Table 3. Relationships between tumor margin type 
and mammography findings
Margin
Well defined 
and rough Indistinct P-value
Microcalcifications 0.849 
 Present 17 27
 Absent 32 46
Architectural distortion 0.099 
 Present 3 13
 Absent 46 60
Breast density 0.178 
 < 50% 28 51
 ≥ 50% 21 22
DISCUSSION
This study showed that breast cancers with well-defined 
and rough margins on ultrasound had a high nuclear 
grade and MIB-1 index, suggesting that they have a 
higher degree of malignancy and greater proliferative 
capacity. Additionally, well-defined and rough margins 
on ultrasound were more likely to be solid-tubular carci-
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reported that breast cancers of low malignancy (histo-
logical grades 1 and 2) showed spiculated margins and 
echogenic halos around lesions attributed to a stromal 
reaction, while highly malignant breast cancers (his-
tological grade 3) did not cause a stromal reaction and 
appeared as a round mass. It is likely that invasive duc-
tal carcinomas with well-defined and rough margins, 
as seen in this study, were highly proliferative without 
causing a stromal reaction, and therefore grew by push-
ing the surrounding tissues. This theory is in agreement 
with another set of findings indicating that such invasive 
ductal carcinomas were often solid-tubular carcinomas 
with relatively clear margins and that accentuation of 
the posterior features was caused by enrichment of the 
cellular component. Conversely, invasive ductal carci-
nomas with indistinct margins were thought to be of 
low malignancy and caused Indian filing invasion and 
stromal reaction, resulting in indistinctive margins on 
the sonogram. Furthermore, fine stands of cancer cells 
infiltrating into the surrounding tissue appeared to cause 
backscattering, resulting in posterior shadowing.
 Several studies have examined the relationships 
between ultrasound images and pathological findings. 
Çelebi et al.11 showed that hormone receptor-positive 
breast cancers showed noncircumscribed margins with 
posterior shadowing, while TNBCs showed circum-
scribed margins. Additionally, Aho et al.12 demonstrated 
that breast cancers showing shadowing or unchanging 
posterior features were histologically low-grade and 
ER-positive, while those showing enhanced posterior 
features were ER-negative. Furthermore, breast cancers 
with circumscribed margins, especially those in elderly 
patients, were highly malignant and hormone recep-
tor-negative. These previous findings are in good agree-
ment with our findings that invasive ductal carcinoma 
without indistinct margins were of nuclear grade 3 and 
hormone receptor-negative.
 Lamb PM et al.13 reported that breast cancers with 
shadowing posterior features on ultrasound were of his-
tological grade 1, but they reported no significant differ-
ences in ultrasound findings regarding margins. Çeleci 
et al.11 speculated that this was because the Breast Imag-
ing Reporting and Data System Lexicon for Ultrasound 
was not used to classify the ultrasound findings. Further-
more, in contrast to our findings, Rotstein and Neerhut14 
showed that grade 3 invasive ductal carcinoma showed 
spiculated, microlobulated, and angular margins. How-
ever, Rotstein and Neerhut examined histological grade 
3 cases only, and did not compare them with grade 1 
and 2 cases; this may explain the difference from our 
findings.
 TNBC is reportedly highly malignant, and the 
Table 4. Relationships between tumor margin type 
and pathological findings
Margin
Well defined 
and rough Indistinct P-value
MIB-1 index, % 31.0(22.0–44.0)
20.1
(13.0–32.0) 0.001
Histological classifi-
cation < 0.001
Papillotubular 
carcinoma 16 24
Solid-tubular 
carcinoma 21 8
Scirrhous carci-
noma 12 41
ER 0.046 
 Positive 39 68
 Negative 10 5
PgR 0.008 
 Positive 32 63
 Negative 17 10
HER-2 0.635 
 Positive 10 12
 Negative 39 61
Nuclear grade 0.001
 Grade 1 11 34
 Grade 2 12 24
 Grade 3 26 15
TNBC 0.003 
 TNBC 8 1
 non-TNBC 41 72
Lymphatic vessel invasion 0.848 
 Present 19 26
 Absent 30 47
Blood vessel invasion 1.000 
 Present 2 2
 Absent 47 71
Lymph node metastasis 0.217 
 Present 17 17
 Absent 32 56
Variables of MIB-1 index are reported as median (interquartile 
range). ER, estrogen receptor; HER2, human epidermal growth 
factor receptor type 2; PgR, progesterone receptor; TNBC, tri-
ple-negative breast cancer.
nomas than indistinct margins. Additionally, almost all 
cases of TNBC were observed among the tumors with 
well-defined and rough margins.
 Highly proliferative breast cancers reportedly do 
not induce a stromal reaction and thus show pushing 
borders, while poorly proliferative tumors induce a des-
moplastic reaction resulting in the formation of dense 
fibrous tissue.7–9 Additionally, Boisserie-Lacroix et al.10 
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histological grade, nuclear grade, and Ki-67 level are 
higher and the prognosis is poorer than those of other 
subtypes.15–18 In terms of the relationship between ul-
trasound findings and breast cancer subtypes, TNBC is 
often associated with circumscribed margins, no shad-
owing of posterior features, marked hypoechogenicity, 
no calcification, and a large depth/width ratio.19, 20 How-
ever, about 18% of TNBC tumors had circumscribed 
margin,21 and TNBCs itself were about only 15% of all 
breast cancer.22 Thus, TNBC tumors with circumscribed 
margins are small part in all breast cancer, and it was 
thought that many of tumors with circumscribed margin 
would be benign lesions. Actually, tumors with cir-
cumscribed margin were only three cases in this study. 
Furthermore, our study also showed that there were 
more TNBCs among invasive ductal carcinomas with 
well-defined and rough margins than among those with 
indistinct margins. 
 In this study, the patients with large tumors were ex-
cluded because they received neoadjuvant chemotherapy. 
This result may explain that there was no relationship 
between tumor margin types and tumor size. 
 Poor prognostic factors of invasive ductal carcinoma 
include young age, vessel invasion, high tumor diameter, 
high nuclear grade, high histological grade, high degree 
of proliferation, absence of hormone receptor expression, 
overexpression of HER2, and lymph node metastasis.6, 
23, 24 In addition, the expression levels of the hormone 
receptors Ki-67 and HER2 are particularly important in 
determining the optimal therapeutic strategy.6 The pres-
ent study showed that invasive ductal carcinomas with 
well-defined and rough margins on ultrasound com-
prised a large proportion of hormone receptor-negative 
cancers, high nuclear grades, TNBCs and high MIB-
1 indices, suggesting a poor prognosis in these cases. 
This knowledge can predict important prognostic and 
therapeutic factors such as the proliferative potential and 
expression levels of hormones by ultrasound, making it 
possible to predict the prognosis and determine the opti-
mal therapeutic strategy earlier. 
 Our study has several limitations. First, our results 
are not applicable to noninvasive carcinoma or invasive 
carcinoma of special types because these carcinomas 
were excluded in this study. Second, the amount of stro-
mal tissue changes and invasion types were not assessed 
by histopathology. This needs to be done to investigate 
the relationship between histopathologic findings and 
ultrasound findings.
 In conclusion, invasive ductal carcinomas with 
well-defined and rough margins on ultrasound are more 
likely to be malignant and proliferative than those with 
indistinct margins.
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